Down-modulation of B cell signal transduction by ligation of mucins to CD22
- 12 May 2008
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 372 (1) , 45-50
- https://doi.org/10.1016/j.bbrc.2008.04.175
Abstract
No abstract availableKeywords
Funding Information
- Core Research for Evolutional Science and Technology
This publication has 24 references indexed in Scilit:
- Siglecs—the major subfamily of I-type lectinsGlycobiology, 2005
- Masking of CD22 by cis ligands does not prevent redistribution of CD22 to sites of cell contactProceedings of the National Academy of Sciences, 2004
- Transitional and marginal zone B cells have a high proportion of unmasked CD22: implications for BCR signalingInternational Immunology, 2003
- New Aspects of Siglec Binding Specificities, Including the Significance of Fucosylation and of the Sialyl-Tn EpitopeJournal of Biological Chemistry, 2000
- Masking and unmasking of the sialic acid-binding lectin activity of CD22 (Siglec-2) on B lymphocytesProceedings of the National Academy of Sciences, 1998
- CD22, A B LYMPHOCYTE–SPECIFIC ADHESION MOLECULE THAT REGULATES ANTIGEN RECEPTOR SIGNALING*Annual Review of Immunology, 1997
- Mucin glycoproteins in neoplasiaGlycoconjugate Journal, 1996
- Synthesis and secretion of mucin by the human colonic tumour cell line LS180Biochemical Journal, 1994
- Natural ligands of the B cell adhesion molecule CD22 beta can be masked by 9-O-acetylation of sialic acids.The Journal of cell biology, 1994
- Correlation of Expression of H/LeY/LeBAntigens with Survival in Patients with Carcinoma of the LungNew England Journal of Medicine, 1992